R&D Allocation
Transporting Cell Therapies Without Refrigeration
ARPA-H's BoSS program is funding preservation materials and processes intended to let therapeutic cells withstand room-temperature storage.
Frozen card revision. This is the recorded reading, not an automatically refreshed view. Current card ↗
R&D Allocation · TOPIC v1
Can cells retain their function through room-temperature storage and transport?
Read article → Transporting Cell Therapies Without Refrigeration
2026-09-29 15:11:40.000 UTC · Last recorded update
Recorded editorial state, not a maturity score
Recorded a new question and follow-up checks from the approved manuscript.
Permanent link to this revision ↗Can cells retain their function through room-temperature storage and transport?
Cell preservation / metabolic suppression / drying
Storage and transport technologies can address a constraint shared by multiple cell-based products.
This is a development funding plan, not a report of practical room-temperature preservation.
Storage duration by cell type, recovered function and independent ATCC testing.
What would change our view: Reconsider if viable cells fail to recover required functions, or adoption costs outweigh convenience.
A prospective test proposal, not a prediction score. A graph connection does not validate this hypothesis.
Who checks clinical AI decisions, and how is that supervision itself evaluated?
Mentioned in this issue
Recorded a new question and follow-up checks from the approved manuscript.
Reading at the time: BoSS announced three development teams and independent testing by ATCC, with up to $87 million planned over four years.
Earlier entries will appear here once more than five reader-facing revisions have accumulated.
公式発表 ↗
arpa-h.gov · recorded 2026-09-29 · linked-primary-source
プログラム概要 ↗
arpa-h.gov · recorded 2026-09-29 · linked-primary-source
ATCCのサービス ↗
www.atcc.org · recorded 2026-09-29 · linked-primary-source